Clinical Trial Update: ACROSS-Cypher Total Occlusion Study of Coronary Arteries 4 Trial [Phase 3]

View source ↗

Summary

The Phase 3 ACROSS-Cypher Total Occlusion Study of Coronary Arteries 4 has completed, evaluating a Cypher sirolimus-eluting stent in patients with coronary occl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Cypher Sirolimus-Eluting Coronary Stent (sirolimus-eluting coronary stent)

Snippet

Sponsor: Sunil Rao | Conditions: Coronary Occlusions | Phase 3 | Status: COMPLETED